A Multicenter, Open-label, Parallel-group Study in Study Participants With Epilepsy, to Evaluate the Effect of Oxcarbazepine on the Pharmacokinetics, Safety, and Tolerability of Padsevonil
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2019
Price : $35 *
At a glance
- Drugs Oxcarbazepine (Primary) ; Padsevonil (Primary) ; Brivaracetam; Lamotrigine; Levetiracetam
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Biopharma
- 12 Jun 2019 Status changed from recruiting to completed.
- 08 May 2019 Planned End Date changed from 1 May 2019 to 1 Jun 2019.
- 08 May 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Jun 2019.